Context Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	76.94	94.43	14.45	35.5	49.64	0.29
Cash & Short-Term Investments	76.94	94.43	14.45	35.5	49.64	0.29
Cash Growth	-9.27%	553.50%	-59.29%	-28.48%	16976.13%	28.27%
Prepaid Expenses	1.92	3.47	1.6	2.36	1.62	0.01
Total Current Assets	79.06	97.9	16.05	37.85	51.26	0.3
Property, Plant & Equipment	0.17	0.23	0.02	0.08	-	-
Long-Term Deferred Charges	-	-	-	-	-	0.12
Other Long-Term Assets	-	-	-	0.03	0.05	0.05
Total Assets	79.23	98.13	16.06	37.97	51.31	0.47
Accounts Payable	2.72	1.45	2.38	0.94	1.83	2.71
Accrued Expenses	3.16	1.14	1.8	2.13	1.12	0.96
Short-Term Debt	-	-	-	-	-	5.83
Current Portion of Long-Term Debt	-	-	-	-	-	0.06
Current Portion of Leases	0.12	0.11	-	0.06	-	-
Other Current Liabilities	0.03	0.05	0.01	0.08	0.09	-
Total Current Liabilities	6.04	2.75	4.19	3.21	3.03	9.55
Long-Term Debt	-	-	-	-	-	0.07
Long-Term Leases	0.02	0.11	-	-	-	-
Other Long-Term Liabilities	-	-	-	-	-	0.03
Total Liabilities	6.06	2.86	4.19	3.21	3.03	9.65
Common Stock	0.09	0.09	0.02	0.02	0.02	0
Additional Paid-In Capital	190.96	189.96	79.91	78.83	77.51	1.88
Retained Earnings	-117.88	-94.78	-68.05	-44.09	-29.25	-18.8
Total Common Equity	73.17	95.27	11.87	34.76	48.27	-16.92
Shareholders' Equity	73.17	95.27	11.87	34.76	48.27	-9.18
Total Liabilities & Equity	79.23	98.13	16.06	37.97	51.31	0.47
Total Debt	0.14	0.22	-	0.06	-	5.95
Net Cash (Debt)	76.8	94.21	14.45	35.44	49.64	-5.66
Net Cash Growth	-9.18%	551.98%	-59.23%	-28.59%	-	-
Net Cash Per Share	0.84	1.61	0.91	2.22	17.52	-2.76
Filing Date Shares Outstanding	91.88	89.7	15.97	15.97	15.97	0.33
Total Common Shares Outstanding	91.88	89.7	15.97	15.97	15.97	0.33
Working Capital	73.02	95.15	11.86	34.65	48.22	-9.25
Book Value Per Share	0.80	1.06	0.74	2.18	3.02	-51.00
Tangible Book Value	73.17	95.27	11.87	34.76	48.27	-16.92
Tangible Book Value Per Share	0.80	1.06	0.74	2.18	3.02	-51.00

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q